Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapy

Figure 1

Influence of adjuvant chemotherapy on overall survival after potentially curative resection of colorectal liver metastases depending on patients’ risk status. A. Overall survival of patients with a MSKCC-CRS ≤ 2 stratified for the type of adjuvant therapy (p = 0.53). B. Overall survival of patients with a MSKCC-CRS > 2 stratified for the type of adjuvant therapy (p = 0.007). Data are presented as Cox proportional hazards.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us